1. |
Yeh S, Kim SJ, Ho AC, et al. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2015, 122(4): 769-778. DOI: 10.1016/j.ophtha.2014.10.013.
|
2. |
Tsuiki E, Suzuma K, Ueki R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion[J]. Am J Ophthalmol, 2013, 156(3): 543-547. DOI: 10.1016/j.ajo.2013.04.008.
|
3. |
Du KF, Xu L, Shao L, et al. Subfoveal choroidal thickness in retinal vein occlusion[J]. Ophthalmology, 2013, 120(12): 2749-2750. DOI: 10.1016/j.ophtha.2013.08.031.
|
4. |
Yumusak E, Ornek K, Dikel NH. Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion[J]. Eur J Ophthalmol, 2016, 26(6): 627-632. DOI: 10.5301/ejo.5000734.
|
5. |
Park J, Lee S, Son Y. Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion[J]. Int J Ophthalmol, 2016, 9(7): 999-1005. DOI: 10.18240/ijo.2016.07.11.
|
6. |
Vinković M, Bosnar D, Tedeschi Reiner E, et al. Combined treatment with bevacizumab and triamcinolone acetonide for macular edema due to retinal vein occlusion[J]. Acta Clin Croat, 2020, 59(4): 569-575. DOI: 10.20471/acc.2020.59.04.01.
|
7. |
Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion[J]. Graefe's Arch Clin Exp Ophthalmol, 2006, 244(3): 309-315. DOI: 10.1007/s00417-004-1087-4.
|
8. |
Pranata R, Vania A, Vania R, et al. Intravitreal ranibizumab versus dexamethasone implant in macular edema due to branch retinal vein occlusion: systematic review and meta-analysis[J]. Eur J Ophthalmol, 2021, 31(4): 1907-1914. DOI: 10.1177/1120672120947595.
|
9. |
Hykin P, Prevost AT, Vasconcelos JC, et al. Clinical effectiveness of intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for macular edema secondary to central retinal vein occlusion: a randomized clinical trial[J]. JAMA Ophthalmol, 2019, 137(11): 1256-1264. DOI: 10.1001/jamaophthalmol.2019.3305.
|
10. |
Eliwa TF, Hegazy OS, Mahmoud SS, et al. Choroidal thickness change in patients with diabetic macular edema[J]. Ophthalmic Surg Lasers Imaging Retina, 2017, 48(12): 970-977. DOI: 10.3928/23258160-20171130-03.
|
11. |
Rewbury R, Want A, Varughese R, et al. Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema[J]. Eye (Lond), 2016, 30(12): 1568-1572. DOI: 10.1038/eye.2016.187.
|
12. |
Coban-karatas M, Altan-yaycioglu R, Ulas B, et al. Choroidal thickness measurements with optical coherence tomography in branch retinal vein occlusion[J]. Int J Ophthalmol, 2016, 9(5): 725-729. DOI: 10.18240/ijo.2016.05.16.
|
13. |
Chung YK, Shin JA, Park YH. Choroidal volume in branch retinal vein occlusion before and after intravitreal anti-VEGF injection[J]. Retina, 2015, 35(6): 1234-1239. DOI: 10.1097/IAE.0000000000000455.
|
14. |
Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy[J]. Retina, 2011, 31(8): 1603-1608. DOI: 10.1097/IAE.0b013e31820f4b39.
|
15. |
Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond[J]. Surv Ophthalmol, 2013, 58(5): 387-429. DOI: 10.1016/j.survophthal.2012.12.001.
|
16. |
Kim KH, Lee DH, Lee JJ, et al. Regional choroidal thickness changes in branch retinal vein occlusion with macular edema[J]. Ophthalmologica, 2015, 234(2): 109-118. DOI: 10.1159/000437276.
|
17. |
Kang HM, Kwon HJ, Yi JH, et al. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration[J]. Am J Ophthalmol, 2014, 157(5): 1013-1021. DOI: 10.1016/j.ajo.2014.01.019.
|
18. |
Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema[J]. Am J Ophthalmol, 2015, 159(1): 85-91. DOI: 10.1016/j.ajo.2014.09.033.
|
19. |
Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion[J]. Br J Ophthalmol, 2019, 103(1): 55-59. DOI: 10.1136/bjophthalmol-2018-311898.
|
20. |
Okamoto M, Yamashita M, Sakamoto T, et al. Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion[J]. Retina, 2018, 38(3): 550-558. DOI: 10.1097/IAE.0000000000001566.
|
21. |
Akay F, Gundogan FC, Yolcu U, et al. Choroidal thickness in systemic arterial hypertension[J]. Eur J Ophthalmol, 2016, 26(2): 152-157. DOI: 10.5301/ejo.5000675.
|
22. |
Kong M, Kwun Y, Sung J, et al. Association between systemic hypertension and macular thickness measured by optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2015, 56(4): 2144-2150. DOI: 10.1167/iovs.14-16080.
|
23. |
Teruyo T, Shou O, Masanori F, et al. Long-term follow-up changes of central choroidal thickness thinning after repeated anti-VEGF therapy injections in patients with central retinal vein occlusion-related macular edema with systemic hypertension[J]. Ophthalmologica, 2020, 243(2): 102-109. DOI: 10.1159/000504754.
|
24. |
Fukami M, Iwase T, Yamamoto K, et al. Changes in retinal microcirculation after intravitreal ranibizumab injection in eyes with macular edema secondary to branch retinal vein occlusion[J]. Invest Ophthalmol Vis Sci, 2017, 58(2): 1246-1255. DOI: 10.1167/iovs.16-21115.
|
25. |
Flores-moreno I, Lugo F, Duker JS, et al. The relationship between axial length and choroidal thickness in eyes with high myopia[J]. Am J Ophthalmol, 2013, 155(2): 314-319. DOI: 10.1016/j.ajo.2012.07.015.
|
26. |
Ooto S, Hangai M, Yoshimuta N. Effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography[J]. Curr Eye Res, 2015, 40(2): 213-225. DOI: 10.3109/02713683.2014.952828.
|
27. |
Rayess N, Rahimy E, Ying GS, et al, et al. Baseline choroidal thickness as a predictor for teatment outcomes in central retinal vein occlusion[J]. Am J Ophthalmol, 2016, 171: 47-52. DOI: 10.1016/j.ajo.2016.08.026.
|